The company has three major R&D and innovation bases: Suzhou, Nanjing, and Heze, located in Suzhou Industrial Park, Nanjing National Jiangning High tech Industrial and Innovative Characteristic Park, and Ruiying Industrial Park. These three bases can effectively meet the needs of various talents for entrepreneurship and development.

On the basis of the innovation base, the company has built eight major technology platforms, which are respectively led by the following leading talents.

Drug Microbial Screening Platform: Led by President Peng Jixian, we are committed to the screening, optimization, and establishment of drug evaluation systems for microbial strains. Currently, we have successfully established a liquid culture system for Helicobacter pylori and the first HP drug screening platform in China

Enzyme design and construction platform: led by Dr. Cai Guozhen, dedicated to gene recombination and construction, gene modification and modification, enzyme design and construction, which can greatly simplify production steps, reduce production costs, and reduce environmental pollution

Chemical Synthesis and Special Chemistry Platform: Led by Dr. Han Ying, it has established specialized laboratories for chemical synthesis, fermentation, bacterial strain extraction, analysis and purification, polymer materials, and environmental research. The laboratory standards are first-class in China, with complete equipment and advanced testing methods, which can fully meet the needs of new product experiments, testing, pilot testing, and scaling up

Innovative drug research and development platform: led by Professor Shang Jing, dedicated to the screening, optimization, and preclinical research of innovative drugs, including modern research and development of traditional Chinese medicine, especially ethnic medicine. Currently, the research and development direction is focused on skin diseases such as cardiovascular and cerebrovascular diseases, lipid metabolism disorders, skin allergies, vitiligo, and psoriasis

Registration and Quality Research Platform: With over 20 years of experience, it is a comprehensive quality research and third-party inspection institution that integrates drugs, food, chemicals, cosmetics, etc. It can undertake product registration, quality research, third-party testing and other services

Pilot and Transformation Platform: With over 20 years of experience in optimizing bacterial strains, fermentation, chemical synthesis, crystallization control, sterile management, and formulation production, as well as CGMP standardized workshops and various advanced equipment and facilities, we can provide products ranging from milligrams to tons

Environmental Protection Technology Platform: This platform not only has environmental protection design and equipment construction and installation qualifications, but also has more than 20 years of experience in three waste treatment and system solutions. Currently, its technology has been successfully promoted in multiple domestic companies

Big Health Platform: Adhering to the health concept of "treating diseases before they occur", we have successfully developed the "Luwei Yuan" big health brand and a series of pure natural big health products. Currently, a series of products with significant effects such as lipid-lowering and liver protection, enhancing male sexual function, and Helicobacter pylori positive conversion to negative have been launched in the market

Environmental protection technology platform: It has an equipment engineering manufacturing company and a sewage treatment center, with the ability to independently research and develop large and medium-sized pharmaceutical production equipment. It has an environmental protection treatment device with an annual processing capacity of 10000m3 and has obtained multiple utility model invention patents.

Industrial Platform Chapter

The four major industrial support platforms and their six production transformation platforms are effective guarantees for the timely and effective transformation of Ruiying Technology's research and development achievements.

The four major industrial support platforms of Ruiying are herb cultivation, pharmaceuticals, big health, and environmental protection, while cultivation, biological fermentation, chemical synthesis, raw materials, sterile raw materials, and formulations are the six major production and transformation platforms of Ruiying. At the same time, this platform is also the most complete industrial chain platform in China.

Four major industry support platforms, including:

Medicinal herb cultivation industry: The company has established two major medicinal herb cultivation bases in Xinjiang and Shandong that comply with GAP standards, fully utilizing the traditional authentic Chinese medicinal herb resources in these two regions

Pharmaceutical Industry: Ruiying is the core industry of Ruiying, with over 500 products in various categories such as anti infection, cardiovascular and cerebrovascular diseases, digestive system, skin diseases, anti-tumor, and more than 20 years of production experience. It has more than 100 automated advanced production lines that meet the requirements of various drug production. Multiple production lines in the factory have passed FDA, EDQM, KFDA, Chinese GMP, ISO9001, and EHS certifications, and the technology and quality of multiple products have always been at the leading level in China, with some products reaching world-class levels

Big Health Industry: Using authentic Chinese medicinal materials with the same origin as food and medicine, combined with modern pharmaceutical technology and evidence-based medicine needs, we have developed a series of "Le Wei Yuan" brand products. Currently, the products on the market mainly include the "Cassia" series, which focuses on "lipid-lowering and liver protection", and the "Lanyou" series, which focuses on "regulating respiration and normal Helicobacter pylori in the gastrointestinal tract"

Environmental protection industry: The company is based on the three wastes generated by its own production platform, and has established a collection and centralized treatment system for wastewater, exhaust gas, and solid waste. It has also formed a comprehensive and integrated environmental protection treatment system, including environmental technology research and development, environmental engineering operation, and comprehensive environmental protection treatment. It has the qualifications for entrusted operation of sewage treatment and equipment design, manufacturing, and installation. It has 36 environmental research personnel and more than 100 management and operation personnel

Six major production conversion platforms, including:

Planting: The medicinal materials required for the "Lewei Yuan" health brand are all grown by the company itself, which not only effectively ensures the medicinal properties of authentic medicinal materials, but also ensures a stable source of goods and the quality of raw materials. Based on modern pharmaceutical technology and inquiry medicine, the developed and produced functional foods have clear characteristics and can truly play a role in "preventing diseases before they occur"

Biological fermentation: With 2 fermentation plants (one of which is a joint venture with Hong Kong Liguo) and a fermentation unit of 5000 cubic meters, including a platform for screening and optimizing strains, enzyme construction and preparation, investigation and screening of active drugs, and a 5000 cubic meter biological fermentation platform, it can meet the transformation needs of various types of biological products and can undertake comprehensive cooperation with external parties for fermentation products

Chemical synthesis: There are 3 chemical synthesis factories and 12 workshops, with over 3000 sets of various synthesis unit equipment and facilities, including more than 3000 sets of high-pressure, low-temperature, high vacuum, resin, ozone, freezing and other series of equipment. The process is fully data-driven and controlled, and key equipment that matches the process is self-made, which can meet the synthesis needs of most products

API: With an annual production capacity of over 3000 tons, it has both solvent crystallization facilities and freeze-drying facilities, which can meet the GMP production needs of tumor drugs, non cephalosporins, cephalosporins, and semi cephalosporins

Sterile raw materials: With an annual production capacity of 500 tons, it is mainly used for the production of cephalosporins and semi cyanobacteria. There are six production lines for solvent crystallization and freeze-drying, mainly supplied to well-known domestic and foreign manufacturers

Pharmaceutical preparations: There are 6 workshops that can meet the GMP production requirements for anti-tumor, injection (including powder injection, injection, pre filled injectors), oral solid preparations (including tablets, capsules, double-layer tablets, etc.), and ointments.